收藏切换
Research progress on mechanism of quercetin in improving polycystic ovary syndrome
收藏切换
Chinese Traditional and Herbal Drugs | 2025, 56(13) : 4852 - 4865
Less
收藏切换
Chinese Traditional and Herbal Drugs | 2025, 56(13): 4852-4865
Research progress on mechanism of quercetin in improving polycystic ovary syndrome
Full
SHI Baichao1, WANG Yu2, CHANG Hui2, LU Fengjuan1, GUAN Muxin1, YU Jiannan1, GAO Zhuwei1, WU Xiaoke2
Affiliations
    1 School of Graduate, Heilongjiang University of Chinese Medicine, Harbin 150040, China; 2 The First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin 150040, China
About Author:
黑龙江省卵巢疾病临床医学研究中心 (LC2020R009); 国中医药科技中药便函[2023]24号; 黑龙江省中医药学会2022—2024年度青年人才托举工程项目 (2022-QNRC1-02)
doi: 10.7501/j.issn.0253-2670.2025.13.028
Outline
收藏切换
Polycystic ovary syndrome (PCOS) is a prevalent reproductive endocrine disease characterized by marked clinical heterogeneity. While the etiology of PCOS remains incompletely understood, it is closely associated with genetic, metabolic, endocrine and environmental factors. To date, no disease-modifying agents specifically targeting PCOS have been established, with current therapeutic strategies focusing solely on symptom management. Quercetin demonstrates multifaceted pharmacological properties including anti-inflammatory, antioxidant, hypoglycemic, and hypocholesterolemic effects, alongside endothelial function improvement. Research has shown that quercetin ameliorates clinical manifestations of PCOS, such as obesity, dysregulated sex hormone profiles, and polycystic ovarian morphology, through its bioactive properties. Nevertheless, the precise mechanistic underpinnings remain incompletely elucidated. Given this, focusing on the diverse pathological pathways implicated in PCOS, this review explores quercetin's mechanisms of action to provide insights for clinical translation and pharmaceutical development.
polycystic ovary syndrome  /  quercetin  /  ameliorating glucose metabolism abnormalities  /  ameliorating dyslipidemia  /  ameliorating chronic inflammation and oxidative stress
石百超, 王宇, 常惠, 卢凤娟, 关木馨, 余健楠, 高竹薇, 吴效科. 槲皮素改善多囊卵巢综合征的作用机制研究进展. 中草药, 2025 , 56 (13) : 4852 -4865 . DOI: 10.7501/j.issn.0253-2670.2025.13.028
SHI Baichao, WANG Yu, CHANG Hui, LU Fengjuan, GUAN Muxin, YU Jiannan, GAO Zhuwei, WU Xiaoke. Research progress on mechanism of quercetin in improving polycystic ovary syndrome[J]. Chinese Traditional and Herbal Drugs, 2025 , 56 (13) : 4852 -4865 . DOI: 10.7501/j.issn.0253-2670.2025.13.028
Year 2025 volume 56 Issue 13
43
0
Cite this Article
BibTeX
Article Info
doi: 10.7501/j.issn.0253-2670.2025.13.028
  • Receive Date:2025-02-14
  • Online Date:2026-11-12
Article Data
Affiliations
History
  • Received:2025-02-14
Affiliations
References
Share
https://castjournals.cast.org.cn/joweb/zcy/EN/10.7501/j.issn.0253-2670.2025.13.028
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT